Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers

RedDress

Status: Enrolling

Conditions: Cutaneous Wounds

Treatments: Device: ActiGraft

Study type: Observational

Funder types: Industry

Identifiers

NCT04699305

RD005

Details and patient eligibility

About

Multicenter observational study to explore the efficacy of ActiGraft in the treatment of exuding cutaneous wounds in real-life usage.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subject is ≥18 years of age
• Subject has an exuding cutaneous wound
• Subject agrees to the use of his health data, including photos of his wound in analysis and publications
• Subject/LAR must be able to read and understand English and/or Spanish

Exclusion criteria

• Subject/LAR is unable to read and understand English or Spanish.

Trial design

500 participants in 1 patient group

ActiGraft

Description:

Whole blood clot (WBC) gel

Treatment:

Device: ActiGraft